| ProductNum | picture | CAS No. | Name and description | Formula | Quick order | 
|---|---|---|---|---|---|
| CLA1678 | 
                         | 
                    2329669-78-3 | 
                         Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223) 95+%  | 
                    — | |
| CLA1666 | 
                         | 
                    2329669-72-7 | 
                         Anti-Human PD-1xCTLA-4 Bispecific Antibody(Vudalimab;XmAb-20717,cytotoxic T-lymphocyte-associated protein 4, CD152;programmed cell death 1, PD1, PD-1, CD279) 95+%  | 
                    — | |
| CLA1592 | 
                         | 
                    332348-12-6 | 
                         Abatacept (Synonyms: CTLA4lg; BMS-188667) 95+%  | 
                    — | |
| CLA1189 | 
                         | 
                    745013-59-6 | 
                         Tremelimumab (anti-CTLA-4) 95+%  | 
                    — | |
| CLA1494 | 
                         | 
                    2394841-59-7 | 
                         Anti-Human PD-1xCTLA-4 Bispecific Antibody(Cadonilimab) 95+%  | 
                    — | |
| CLA1010 | 
                         | 
                    477202-00-9 | 
                         Anti-CTLA4 (ipilimumab biosimilar) mAb 98+%  | 
                    — | |